ERAPREVE

Welcome to the Brand page for “ERAPREVE”, which is offered here for Pharmaceutical preparations for the treatment of cardiovascular system diseases, heart diseases and blood diseases; pharmaceutical preparations for the treatment of central nervous system disorders, stroke and dementia; pharmaceutical preparations for the treatment of ophthalmological disorders, glaucoma; pharmaceutical preparations for the treatment of respiratory system diseases, pulmonary diseases; pharmaceutical preparations for the treatment of renal diseases; pharmaceutical preparations for use in surgical procedures and organ transplantation to prevent reperfusion injury;.

Its status is currently believed to be active. Its class is unavailable. “ERAPREVE” is believed to be currently owned by “Mitsubishi Pharma Corporation”.